“The lotus leaf has given us a wonderful example of a self-cleaning system, designed by nature. ”

– Queen's chemist Dr. Guojun Liu on his amphiphobic materials


Made-in-Ontario photovoltaic technology generates buzz at international solar showcase

Sept. 15, 2010

A solar power technology developed at Queen’s University has been pegged by installers, distributors and manufacturers as a potential game-changer in the solar  industry.

Publicly launched at North America’s largest solar conference and trade show in San Francisco recently, the compact, lightweight power converter – also known as a microinverter – offers a lower cost, next-generation solution to harvesting the power of the sun for household use.

Ontario awards $2.5 million to Queen’s startup company to expand advanced monitoring platform for municipal water systems


Funding accelerates growth of ENDETEC, global sensor platform of Veolia Water Solutions & Technologies

May 26, 2010

KINGSTON, ON – A Queen’s University startup company founded on university researchers’ determination to find a faster, more effective way to monitor municipal water systems, has received $2.5 million from the Ontario government to expand their product development program in Kingston, Ontario.

Queen’s University prostate cancer research tool licensed to Cymogen Dx

May 5, 2010

KINGSTON, ON/NEW WINDSOR, NY -- A Queen’s University researcher has developed a novel technology for detecting genomic loss of tumor suppressor genes in patient biopsies. The first assay of this broad platform technology will target the ability to determine the loss of the PTEN gene. PTEN plays a critical role in cancers of the prostate, breast, lung, and others. The patent-pending technology has been licensed exclusively to Cymogen Dx of New York.

Non-invasive treatment alternative for prostate cancer among Queen’s cancer research highlighted at Eastern Ontario Innovation Forum

March 10, 2010

KINGSTON, ON – Promising results from a small, early clinical trial for treating prostate cancer will be among the scientific advances highlighted by Queen’s University researchers at Connect for the Cure, an innovation forum focused on cancer research in Eastern Ontario universities, hospitals and cancer centres.

First clinical trial on nitroglycerin to treat prostate cancer shows potential to halt disease

Findings hold promise for PARTEQ-licensed technology

Feb. 4, 2010

KINGSTON, ON -- Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen’s University researchers have discovered.

The findings are the result of the first-ever clinical trial using nitroglycerin to treat prostate cancer.  

Subscribe to RSS - 2010